SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,240.00    30.00 (2.46%)
Bid:
1,230.00
Ask:
1,250.00
Spread: 20.00 (1.626%)
Market Cap: £369.26m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Trading Update

22 Apr 2024 07:00

RNS Number : 3269L
Cerillion PLC
22 April 2024
 

AIM: CER

 Cerillion plc

("Cerillion" or the "Company")

 

Half Year Trading Update

 

Record Six Months

 

Cerillion, the billing, charging and customer relationship management software solutions provider, is pleased to announce an update on trading for the first six months of its current financial year ending 30 September 2024.

 

Results for the six-months ended 31 March 2024 are expected to set new highs for revenue and adjusted EBITDA. Revenue is expected to be approximately £22.5m (H1 2023: £20.5m) and adjusted EBITDA approximately £10.9m (H1 2023: £9.9m), both 10% higher year-on-year. Net cash at 31 March 2024 has increased to approximately £26.6m (31 March 2023: £23.6m), providing a very firm underpinning to the Company's strong balance sheet.  

 

The first half performance reflects ongoing strong demand from customers and the trading backdrop remains favourable. Telco digital transformation, the transition to Software-as-a-Service solutions and investment in enterprise software to achieve revenue and efficiency gains remain key features of the market, and consequently the Company's sales pipeline is strong. It includes a number of substantial potential new contracts, which are at various stages of the negotiation process. The Board believes that the Company remains well-placed to meet market expectations for the current financial year and beyond.

 

Notice of results

 

The Board expects to announce interim results on 13 May 2024, and will provide a further update on current trading at that time. 

 

 

Cerillion plc

c/o KTZ Communications

Louis Hall, CEO

T: 020 3178 6378

Andrew Dickson, CFO

Liberum (Nomad and Broker)

T: 020 3100 2000

Bidhi Bhoma, Ben Cryer, Matthew Hogg

 

 

Singer Capital Markets (Joint Broker)

T: 020 7496 3000

Rick Thompson, James Fischer

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Robert Morton

 

About Cerillion

www.cerillion.com

 

Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management ("CRM"), mainly serving the telecommunications market but also other sectors such as utilities and financial services. The Company currently has over 80 customer installations across over 45 countries. Headquartered in London, Cerillion also has operations in India and Bulgaria.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZGMDRLMGDZG
Date   Source Headline
8th Jun 20265:50 pmRNSPDMR Dealing
1st Jun 20267:00 amRNSInterim Results
19th May 20267:00 amRNSInterim Results Investor Presentation
24th Apr 20262:46 pmRNSTR-1 Notification
22nd Apr 20267:00 amRNSH1 Trading Update
17th Apr 20268:00 amRNSExcercise of Options, Total Voting Rights
14th Apr 20267:00 amRNSCFO Joining Date and Date of Trading Update
9th Apr 202611:43 amRNSTR-1 Notification
27th Mar 20267:00 amRNSTR-1 Notification
26th Mar 20267:00 amRNS-RAchieves "Diamond-level" Open API Certification
5th Mar 202611:44 amRNSGrant of Options
19th Feb 20263:38 pmRNSResult of AGM
18th Feb 20267:00 amRNSNotification of Major Interest in Cerillion
13th Feb 202610:24 amRNSExercise of Options, Total Voting Rights
6th Feb 202610:37 amRNSExercise of Options, TVR, Block Admission Return
2nd Feb 202612:45 pmRNSExercise of Options and Total Voting Rights
28th Jan 20267:00 amRNSBoard Change - CFO Transition
14th Jan 20266:15 pmRNSExcercise of Options and Share Purchase
12th Jan 20269:15 amRNSPosting of Report and Accounts & Notice of AGM
8th Jan 20267:00 amRNSMajor Contract Win
2nd Dec 20255:19 pmRNSTR-1 Notification
24th Nov 20255:56 pmRNSExcercise of Options, PDMR Dealing
24th Nov 20257:00 amRNSFinal Results
3rd Nov 20257:00 amRNSNotice of Final Results
29th Oct 20257:00 amRNS-RLaunch of Cerillion 25.2
23rd Oct 20258:01 amRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSFull Year Trading Update
25th Sep 20257:00 amRNS-RNamed in IDC MarketScape 2025 Assessment
8th Sep 20257:00 amRNSMajor follow-on contracts worth £17.3m
2nd Sep 20257:00 amRNS-RCerillion Recognised in two Gartner Reports
30th Jul 20257:00 amRNSExercise of Options, PDMR dealing and TVR
2nd Jul 20251:14 pmRNSEmployee Share Option Scheme and PDMR dealing
16th Jun 20257:00 amRNSTR-1 Notification
13th Jun 20257:47 amRNSPDMR shareholding - replacement
12th Jun 20251:50 pmRNSResult of Secondary Share Sale
11th Jun 20254:54 pmRNSProposed Secondary Placing
10th Jun 20256:30 pmRNSPDMR Shareholding
5th Jun 20257:37 amRNSDirector/PDMR Shareholding
19th May 20257:00 amRNSInterim Results
16th May 20251:29 pmRNSResult of General Meeting
12th May 20257:00 amRNSNotice of Results and Investor Presentation
30th Apr 20259:06 amRNSNotice of General Meeting
29th Apr 20253:51 pmRNSTR-1 Notification
14th Apr 20257:00 amRNSHalf-year Trading Update
17th Mar 20257:00 amRNSShare Purchase
13th Feb 20254:25 pmRNSResult of AGM
24th Jan 20259:51 amRNSPDMR Shareholding
22nd Jan 20259:35 amRNSPDMR Shareholding
20th Jan 20257:00 amRNSMajor New Contract
15th Jan 20257:00 amRNSShare purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.